Before his investing career, he served in various executive capacities at Boston Scientific Corporation for 15 years ... CellFX nsPFA and the stylized logos are among the trademarks and/or ...

Boston Scientific Corp. closed 0.01% short of its 52-week high of $101.65, which the company reached on January 22nd.

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $102.32 which represents a slight increase of $0.05 or 0.05% from the prior close of $102.27. The stock opened at $102.28 and ...

Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...

Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 5 years ago, it would be worth $2,432.39 today based on a ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI ...

PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...

Boston Scientific's (NYSE:BSX) stock is up by a considerable 12% over the past three months. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...